← Back to Patent Explorer
US5571523A Expired / Lapsed US ⏱️ 0.0 years remaining

Antioxidant-induced apoptosis in vascular smooth muscle cells

Assignee: Harvard University
•
Filing: 1995-03-09
•
Granted: 1996-11-05
•
Expires: 2015-03-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of inhibiting arteriosclerosis or smooth muscle cell proliferation by identifying an animal having an artery suspected of needing such inhibition and contacting the artery with an apoptosis-inducing amount of an antioxidant.

Inventors

  • 👤 Mu-En Lee
  • 👤 Edgar Haber
  • 👤 Jer-Chia Tsai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 02:45
CPC Classifications
A; A61; A61L; A61L29/00; A61L29/14; A61L29/16; A61K; A61K31/00; A61K31/095; A61K31/10; A61K31/185; A61K31/19; A61K31/195; A61K31/197; A61K31/198; A61K31/33; A61K31/38; A61K31/381; A61K31/395; A61K31/41; A61K31/425; A61K31/495; A61K31/505; A61K31/513; A61K38/00; A61K38/04; A61K38/06; A61K38/063; A61P; A61P9/00; A61P9/10; A61L2300/00; A61L2300/40; A61L2300/416; A61L2300/422

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 31 words
A method of inhibiting arteriosclerosis in an animal, comprising identifying an animal having an artery suspected of needing said inhibition and contacting said artery with an apoptosis-inducing amount of an antioxidant.
Claim 2
Independent Claim 31 words
A method of inhibiting arteriosclerosis in an animal, comprising identifying an animal having an artery suspected of needing said inhibition and contacting said artery with an apoptosis-inducing amount of an antioxidant.
Claim 3
Dependent Claim 11 words
The method of claim 1, wherein said animal is a human.
Claim 4
Dependent Claim 12 words
The method of claim 1, wherein said antioxidant is a sulfur-containing antioxidant.
Claim 5
Dependent Claim 12 words
The method of claim 3, wherein said antioxidant comprises a sulfhydryl group.
Claim 6
Dependent Claim 10 words
The method of claim 3, wherein said antioxidant is N-acetylcysteine.
Claim 7
Dependent Claim 10 words
The method of claim 3, wherein said antioxidant is pyrrolidinedithiocarbamate.
Claim 8
Dependent Claim 38 words
The method of claim 3, wherein said antioxidant is chosen from the group consisting of 2-mercaptoethanol, dithiothreitol, glutathione, S-adenosylmethionine, dithiocarbamate, propylthiouracil, dimethylsulfoxide, cysteine, methionine, cysteamine, oxo-thiazolidinecarboxylate, timonacic acid, WR-2721, malotilate, 1,2-dithiol 3-thione, 1,3-dithiol 2-thione, lipoamide, sulfarlem, and oltipraz.
Claim 9
Dependent Claim 16 words
The method of claim 3, wherein said antioxidant is a mixture of two or more antioxidants.
Claim 10
Dependent Claim 12 words
The method of claim 8, wherein said mixture comprises N-acetylcysteine and pyrrolidinedithiocarbamate.
Claim 11
Independent Claim 32 words
A method of inhibiting vascular smooth muscle cell proliferation in an animal, comprising identifying an animal in need of said inhibition, and introducing an antioxidant into a blood vessel of said animal.
Claim 12
Independent Claim 32 words
A method of inhibiting vascular smooth muscle cell proliferation in an animal, comprising identifying an animal in need of said inhibition, and introducing an antioxidant into a blood vessel of said animal.
Claim 13
Dependent Claim 11 words
The method of claim 10, wherein said animal is a human.
Claim 14
Dependent Claim 15 words
The method of claim 10, wherein said proliferation occurs at the site of vascular injury.
Claim 15
Dependent Claim 12 words
The method of claim 10, wherein said antioxidant is a sulfur-containing antioxidant.
Claim 16
Dependent Claim 12 words
The method of claim 13, wherein said antioxidant comprises a sulfhydryl group.
Claim 17
Dependent Claim 10 words
The method of claim 13, wherein said antioxidant is N-acetylcysteine.
Claim 18
Dependent Claim 10 words
The method of claim 13, wherein said antioxidant is pyrrolidinedithiocarbamate.

References Cited (Backward Citations)

US5464833A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-11-05 2000-05-06 2000-11-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-11-05 2004-05-06 2004-11-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-11-05 2008-05-06 2008-11-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag